MROH9: A Protein Interaction Target for Drug Development (G80133)

Target Name: MROH9

NCBI ID: G80133

MROH9

MROH9: A Protein Interaction Target for Drug Development

MROH9 (ARMC11) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MROH (Mucosal-Rubricant Oligomeric) family, which is characterized by the presence of a single transmembrane protein that is involved in various cellular processes.

One of the unique features of MROH9 is its ability to interact with a variety of different molecules, including G protein-coupled receptors (GPCRs), which are a family of membrane receptors that play important roles in cellular signaling. MROH9 has been shown to interact with multiple GPCRs, including the beta-2 adrenergic receptor (尾2AR), which is involved in a wide range of physiological processes, including cardiovascular function and neurotransmission.

GPCRs are a classes of membrane receptors that are characterized by the presence of a transmembrane protein that is involved in the regulation of cellular processes that are critical for maintenance of life. They are involved in a wide range of signaling pathways, including sensory perception, neurotransmission, and hormone signaling. GPCRs are also known for their ability to interact with various proteins, including MROH9, which has been shown to play an important role in the regulation of these processes.

MROH9 is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues. For example, MROH9 has been shown to be involved in the regulation of cell proliferation, differentiation, and survival. It has also been shown to play a role in the regulation of cell migration and the formation of tissues, such as the brain and heart.

In addition to its role in cellular signaling, MROH9 is also involved in the regulation of various cellular processes that are important for maintaining the structure and function of tissues. For example, it has been shown to play a role in the regulation of cytoskeletal organization, cell adhesion, and the regulation of the cytosol-to-endoplasmic reticulum (ER) transport system.

GPCRs are also known for their ability to play a critical role in the regulation of various physiological processes that are important for the survival and health of the body. They are involved in the regulation of cardiovascular function, neurotransmission, and hormone signaling, among other things . MROH9 has been shown to interact with multiple GPCRs, including the 尾2AR, which is involved in the regulation of cardiovascular function and neurotransmission.

The identification of MROH9 as a drug target or biomarker has significant implications for the development of new treatments for a wide range of diseases. MROH9 is involved in a wide range of cellular processes that are important for the survival and function of tissues, and it is possible that it may play a critical role in the development and progression of many different diseases.

In conclusion, MROH9 (ARMC11) is a protein that is expressed in various tissues of the body and is involved in a wide range of cellular processes that are important for the survival and function of tissues. Its ability to interact with multiple GPCRs, including the 尾2AR, makes it a potential drug target or biomarker for the treatment of a wide range of diseases. Further research is needed to fully understand the role of MROH9 in cellular signaling and its potential as a drug target or biomarker.

Protein Name: Maestro Heat Like Repeat Family Member 9

The "MROH9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MROH9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets